BTIG Research

BTIG Research initiated coverage on Kennedy-Wilson Holdings Inc (NYSE: KW) with a Buy rating. The target price for Kennedy-Wilson Holdings is set to $32. Kennedy-Wilson Holdings shares have dropped 3.80 percent over the past 52 weeks, while the S&P 500 index has surged 7.33 percent in the same...

Analysts at BTIG Research upgraded Synchrony Financial (NYSE: SYF) from Neutral to Buy. Synchrony Financial shares rose 0.81 percent to close at $30.52 on Friday.

Analysts at BTIG Research initiated coverage on Madison Square Garden Company (NASDAQ: MSG) with a Buy rating. The target price for Madison Square Garden is set to $110. Madison Square Garden shares have gained 32.45% over the past 52 weeks, while the S&P 500 index has surged 12.21% in the...

Analysts at BTIG Research initiated coverage on Radian Group Inc. (NYSE: RDN) with a Buy rating. The target price for Radian Group is set to $22. Radian Group shares have gained 2.08% over the past 52 weeks, while the S&P 500 index has surged 11.34% in the same period. Radian Group's shares...

Analysts at BTIG Research initiated coverage on Exterran Holdings, Inc. (NYSE: EXH) with a Buy rating. The target price for Exterran Holdings is set to $42. Exterran Holdings shares have dropped 21.82% over the past 52 weeks, while the S&P 500 index has surged 11.80% in the same period....

In a report published Friday, BTIG Research analyst Sean Lavin initiated coverage on Histogenics Corp. (NASDAQ: HSGX) with a Buy rating and $13.00 price target. In the report, BTIG Research noted, “Histogenics' NeoCart is likely to be the first regenerative tissue implant available in the U.S. with...

Analysts at BTIG Research initiated coverage on shares of Histogenics Corporation (NASDAQ: HSGX) with a Buy rating. The target price for Histogenics is set to $13. Histogenics' shares closed at $8.43 yesterday.

In a report published Tuesday, BTIG Research analyst Mark Palmer initiated coverage on On Deck Capital Inc (NYSE: ONDK) with a Buy rating and $25.00 price target. In the report, BTIG Research noted, “We are initiating coverage of OnDeck Capital (ONDK) with a BUY recommendation and a price target of...

Herbalife Ltd. (NYSE: HLF) is down nearly 50 percent over the past six months, but is up more than 3 percent on Thursday. The company is also involved in quite the debate with hedge fund manager Bill Ackman. But what has the rest of Wall Street said about Herbalife in the past few months?...

Analysts at BTIG Research downgraded The Procter & Gamble Company (NYSE: PG) to Neutral. Procter & Gamble shares have gained 13.79% over the past 52 weeks, while the S&P 500 index has surged 13.10% in the same period. Procter & Gamble's shares fell 0.88% to close at $92.64...

Longbow Research downgraded Seagate Technology (NASDAQ: STX) and Western Digital Corporation (NASDAQ: WDC) on Monday, moving both from Buy to Neutral. Although specialist Joe Wittine doesn’t think investors should get rid of these stocks, he does not see as much upside potential in...

Mark Palmer of BTIG Research downgraded shares of Synchrony Financial (NYSE: SYF) to Neutral from Buy after shares recently traded at his $30 price target. “While we continue to be impressed by Synchrony Financial's best-in-class capital ratios, strong liquidity and growing deposit base, we believe...

In a note to clients on Thursday, Richard Greenfield of BTIG downgraded shares of Time Warner Cable Inc (NYSE: TWC) to Neutral from Buy, while no longer issuing a price target. “One year ago, as speculation over Charter Communications' interest in Time Warner Cable grew, we wrote that Time Warner...

Following Nu Skin Enterprises, Inc. (NYSE: NUS) Investor Day, April Scee of BTIG Research commented in a note on Wednesday that the company's China issues are in the past. “At its Investor Day last week, management stressed China should begin to inflect and unveiled its innovation agenda and fiscal...